|Articles|February 9, 2022
- Pharmaceutical Executive-02-01-2022
- Volume 42
- Issue 2
Pharmaceutical Executive, February 2022 Issue (PDF)
Advertisement
Articles in this issue
over 4 years ago
As Change Continues, Are You Digitally Fit For the Future?over 4 years ago
Ready for Pharma’s Next Chapterover 4 years ago
The Tech Perspective: Coordinating a Plan of Engagementover 4 years ago
The Importance of Culturally Inclusive and Relevant Marketingover 4 years ago
Messaging Makeoverover 4 years ago
Ethics of Antibioticsover 4 years ago
What’s Up in Biotech These Days? Not Much, Unfortunatelyover 4 years ago
Planning for Second to Market in Orphan Disease Spaceover 4 years ago
AI and Analytics Appear Ready to Surge in Sales and Marketingover 4 years ago
It’s Time for Companies To See Employees as Full-Time PeopleAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
3
Pharmaceutical Executive Daily: FDA Approves Lipfendra
4
From Dr. Google to Dr. Claude: Why the Most Important Patient Support Innovation Is Still Human Connection
5